Latest Insider Transactions at Codiak Bio Sciences, Inc. (CDAK)
This section provides a real-time view of insider transactions for Codiak Bio Sciences, Inc. (CDAK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Codiak BioSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Codiak BioSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2023
|
Yalonda Howze |
SELL
Open market or private sale
|
Direct |
1,628
-17.92%
|
$0
$0.2 P/Share
|
|
Mar 29
2023
|
Sriram Sathyanarayanan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,762
-100.0%
|
$0
$0.17 P/Share
|
|
Mar 29
2023
|
Nicole Barna |
SELL
Open market or private sale
|
Direct |
7,305
-36.35%
|
$0
$0.17 P/Share
|
|
Mar 28
2023
|
Douglas E Williams President & CEO |
SELL
Open market or private sale
|
Direct |
41,667
-84.48%
|
$0
$0.18 P/Share
|
|
Mar 28
2023
|
Linda Bain Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,412
-100.0%
|
$0
$0.17 P/Share
|
|
Mar 28
2023
|
Konstantin Konstantinov Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
9,364
-89.68%
|
$0
$0.2 P/Share
|
|
Feb 17
2023
|
Yalonda Howze |
SELL
Open market or private sale
|
Direct |
1,603
-15.0%
|
$0
$0.59 P/Share
|
|
Feb 17
2023
|
Nicole Barna |
SELL
Open market or private sale
|
Direct |
1,274
-9.49%
|
$0
$0.59 P/Share
|
|
Feb 17
2023
|
Sriram Sathyanarayanan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,407
-16.99%
|
$0
$0.59 P/Share
|
|
Feb 17
2023
|
Konstantin Konstantinov Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,391
-15.77%
|
$0
$0.59 P/Share
|
|
Feb 17
2023
|
Douglas E Williams President & CEO |
SELL
Open market or private sale
|
Direct |
7,681
-13.47%
|
$0
$0.59 P/Share
|
|
Feb 17
2023
|
Linda Bain Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,570
-16.08%
|
$0
$0.59 P/Share
|
|
Feb 16
2023
|
Kyriazi Theo Melas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+36.31%
|
-
|
|
Feb 16
2023
|
Yalonda Howze |
BUY
Exercise of conversion of derivative security
|
Direct |
4,856
+31.24%
|
-
|
|
Feb 16
2023
|
Nicole Barna |
BUY
Exercise of conversion of derivative security
|
Direct |
3,150
+19.0%
|
-
|
|
Feb 16
2023
|
Charles L Cooney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+50.0%
|
-
|
|
Feb 16
2023
|
Steven Gillis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+50.0%
|
-
|
|
Feb 16
2023
|
Sriram Sathyanarayanan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,350
+34.16%
|
-
|
|
Feb 16
2023
|
Jason Haddock Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+50.0%
|
-
|
|
Feb 16
2023
|
Karen Bernstein Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,750
+50.0%
|
-
|
|
Feb 16
2023
|
Konstantin Konstantinov Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,200
+32.25%
|
-
|
|
Feb 16
2023
|
Douglas E Williams President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,969
+28.72%
|
-
|
|
Feb 16
2023
|
Linda Bain Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,613
+32.27%
|
-
|
|
Jan 20
2023
|
Douglas E Williams President & CEO |
SELL
Open market or private sale
|
Direct |
5,075
-21.83%
|
$0
$0.57 P/Share
|
|
Jan 20
2023
|
Sriram Sathyanarayanan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,082
-38.18%
|
$0
$0.58 P/Share
|
|
Jan 20
2023
|
Konstantin Konstantinov Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,069
-38.18%
|
$0
$0.58 P/Share
|
|
Jan 20
2023
|
Linda Bain Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,880
-37.6%
|
$0
$0.57 P/Share
|
|
Jan 20
2023
|
Nicole Barna |
SELL
Open market or private sale
|
Direct |
836
-9.34%
|
$0
$0.57 P/Share
|
|
Jan 20
2023
|
Yalonda Howze |
SELL
Open market or private sale
|
Direct |
1,512
-37.8%
|
$0
$0.58 P/Share
|
|
Jan 19
2023
|
Douglas E Williams President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,667
+37.02%
|
-
|
|
Jan 19
2023
|
Sriram Sathyanarayanan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,834
+50.0%
|
-
|
|
Jan 19
2023
|
Konstantin Konstantinov Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+50.0%
|
-
|
|
Jan 19
2023
|
Linda Bain Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
-
|
|
Jan 19
2023
|
Nicole Barna |
BUY
Exercise of conversion of derivative security
|
Direct |
2,167
+19.5%
|
-
|
|
Jan 19
2023
|
Yalonda Howze |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
-
|
|
Sep 15
2022
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
933,333
+21.49%
|
-
|
|
Sep 13
2022
|
Arch Venture Fund Viii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000,000
+36.09%
|
$5,000,000
$1.5 P/Share
|
|
Sep 13
2022
|
Steven Gillis Director |
BUY
Open market or private purchase
|
Indirect |
5,000,000
+39.99%
|
-
|
|
Aug 17
2022
|
Yalonda Howze |
SELL
Open market or private sale
|
Direct |
1,512
-20.59%
|
$3,024
$2.21 P/Share
|
|
Aug 17
2022
|
Nicole Barna |
SELL
Open market or private sale
|
Direct |
984
-8.74%
|
$1,968
$2.21 P/Share
|
|
Aug 17
2022
|
Sriram Sathyanarayanan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,283
-25.08%
|
$4,566
$2.21 P/Share
|
|
Aug 17
2022
|
Konstantin Konstantinov Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,308
-22.05%
|
$2,616
$2.21 P/Share
|
|
Aug 17
2022
|
Douglas E Williams President & CEO |
SELL
Open market or private sale
|
Direct |
7,112
-17.28%
|
$14,224
$2.21 P/Share
|
|
Aug 17
2022
|
Linda Bain Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,364
-22.03%
|
$4,728
$2.21 P/Share
|
|
Aug 16
2022
|
Yalonda Howze |
BUY
Exercise of conversion of derivative security
|
Direct |
4,857
+39.81%
|
-
|
|
Aug 16
2022
|
Nicole Barna |
BUY
Exercise of conversion of derivative security
|
Direct |
3,150
+21.86%
|
-
|
|
Aug 16
2022
|
Sriram Sathyanarayanan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,350
+44.68%
|
-
|
|
Aug 16
2022
|
Konstantin Konstantinov Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,200
+41.46%
|
-
|
|
Aug 16
2022
|
Douglas E Williams President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,969
+35.82%
|
-
|
|
Aug 16
2022
|
Linda Bain Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,613
+41.5%
|
-
|